Business
BIO-key sells identity and access management software, biometric technology, cloud identity services, and authentication hardware.
BIO-key narrowed losses and drew insider purchases, but the FY2024 cash-flow deficit and going-concern risk remain central.
The read at a glance✓ Audited against SEC data
- Business mix — Identity and biometricsNote
- Gross profit — Gross profit rose to $5.6MOK
- Loss — Net loss narrowed 49.5%OK
- Cash flow — OCF still -$2.9MWatch
- Debt — Debt down 76.3%OK
- Insiders — 3 purchases / 0 salesOK
- Accounting — Forensic screens unavailableNote
Where the revenue comes from
Fiscal 2025, as BIO KEY INTERNATIONAL INC reports it. History and quarterly detail are in the app.
- License$3.4M
- Hardware$1.3M
- Service$1.2M
Leadership changes
From BIO KEY INTERNATIONAL INC's own filings, the day they're filed.
- Thomas E. Bush III · departureeff. 2023-11-08
Latest filings
- 8-K · Company announcement2026-10-02
- 8-K · Company announcement2026-09-08
- 8-K · Company announcement2026-08-14
- 8-K · Company announcement2026-08-13
- 10-Q · Quarterly report2026-08-13
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about BIO KEY INTERNATIONAL INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.